- Home
- WRN vs EIKN Comparison
WRN vs EIKN Comparison
Compare WRN & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WRN | EIKN |
|---|---|---|
| Founded | 2006 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 401.9M |
| IPO Year | 2006 | 2026 |
Fundamental Metrics
Financial Performance| Metric | WRN | EIKN |
|---|---|---|
| Price | $1.72 | $8.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $5.50 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 1.1M | 498.0K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $6.45 |
| 52 Week High | $4.26 | $16.50 |
Technical Indicators
Market Signals| Indicator | WRN | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 23.93 | 50.99 |
| Support Level | N/A | $7.96 |
| Resistance Level | $2.59 | $10.20 |
| Average True Range (ATR) | 0.08 | 0.59 |
| MACD | -0.02 | 0.19 |
| Stochastic Oscillator | 1.94 | 84.45 |
Price Performance
Historical ComparisonAbout WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project). The Casino can deliver the critical minerals necessary for the energy transition while serving as an engine for long-term economic growth and prosperity in the North.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.